Table 1.
Analysis of gastric cancer patients with DcR3 and ERK1/2 expression in tumor and normal tissues
| Cases | Positive number | Positive rate (%) | ||||||
|---|---|---|---|---|---|---|---|---|
| Tumor |
50 |
mRNA |
Protein |
+/+ |
mRNA |
Protein |
+/+ |
|
| DcR3 |
|
36 |
37 |
28 |
72.0 |
74.0 |
56.0 |
|
| ERK1 |
|
37 |
42 |
36 |
74.0 |
84.0 |
72.0 |
P > 0.05 |
| ERK2 |
|
32 |
37 |
27 |
64.0 |
74.0 |
54.0 |
|
| Non-cancerous |
50 |
|
|
|
|
|
|
|
| DcR3 |
|
2 |
3 |
0 |
4.0 |
6.0 |
0 |
|
| ERK1 |
|
6 |
5 |
1 |
12.0 |
15.0 |
2.0 |
|
| ERK2 | 9 | 10 | 3 | 18.0 | 20.0 | 6.0 | ||